Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Strandberg

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 31, 2006
Evaluation of a rapid automated assay for analysis of von Willebrand ristocetin cofactor activityKarin Strandberg, Stefan Lethagen, Kerstin Andersson, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|April 4, 2025
Cold activation in PT-INR samples - Myth or reality in the modern laboratory?Annika Petersson, Karin Strandberg, Magnus Magnusson, et al.
Journal of Vascular Surgery|May 9, 2006
Activated protein C-protein C inhibitor complex: a new biological marker for aortic aneurysmsTilo Kölbel, Karin Strandberg, Ingrid Mattiasson, et al.
Thrombosis Journal|June 27, 2017
Procoagulatory changes induced by head-up tilt test in patients with syncope: observational studyViktor Hamrefors, Artur Fedorowski, Karin Strandberg, et al.
European Journal of Haematology|October 14, 2019
Clinical utility and impact of the use of the chromogenic vs one-stage factor activity assays in haemophilia A and BRichard A Marlar, Karin Strandberg, Midori Shima, et al.
Plos One|January 28, 2015
Monitoring low molecular weight heparins at therapeutic levels: dose-responses of, and correlations and differences between aPTT, anti-factor Xa and thrombin generation assaysOwain Thomas, Emanuel Lybeck, Karin Strandberg, et al.
Cardiology in the Young|February 7, 2009
Lower incidence of procoagulant abnormalities during follow-up after creation of the Fontan circulation in childrenOlof Rask, Katarina Hanséus, Rolf Ljung, et al.
Journal of Thrombosis and Haemostasis : JTH|April 16, 2020
Unveiling the complex effects of direct oral anticoagulants on dilute Russell's viper venom time assaysAndreas Hillarp, Karin Strandberg, Kerstin M Gustafsson, et al.
Thrombosis Research|May 9, 2009
Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarinMattias Wieloch, Andreas Hillarp, Karin Strandberg, et al.
Journal of Hypertension|July 3, 2015
Higher levels of von Willebrand factor in patients with syncope due to orthostatic hypotensionNazim Isma, Richard Sutton, Andreas Hillarp, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 31, 2006
Evaluation of a rapid automated assay for analysis of von Willebrand ristocetin cofactor activityKarin Strandberg, Stefan Lethagen, Kerstin Andersson, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|April 4, 2025
Cold activation in PT-INR samples - Myth or reality in the modern laboratory?Annika Petersson, Karin Strandberg, Magnus Magnusson, et al.
Journal of Vascular Surgery|May 9, 2006
Activated protein C-protein C inhibitor complex: a new biological marker for aortic aneurysmsTilo Kölbel, Karin Strandberg, Ingrid Mattiasson, et al.
Thrombosis Journal|June 27, 2017
Procoagulatory changes induced by head-up tilt test in patients with syncope: observational studyViktor Hamrefors, Artur Fedorowski, Karin Strandberg, et al.
European Journal of Haematology|October 14, 2019
Clinical utility and impact of the use of the chromogenic vs one-stage factor activity assays in haemophilia A and BRichard A Marlar, Karin Strandberg, Midori Shima, et al.
Plos One|January 28, 2015
Monitoring low molecular weight heparins at therapeutic levels: dose-responses of, and correlations and differences between aPTT, anti-factor Xa and thrombin generation assaysOwain Thomas, Emanuel Lybeck, Karin Strandberg, et al.
Cardiology in the Young|February 7, 2009
Lower incidence of procoagulant abnormalities during follow-up after creation of the Fontan circulation in childrenOlof Rask, Katarina Hanséus, Rolf Ljung, et al.
Journal of Thrombosis and Haemostasis : JTH|April 16, 2020
Unveiling the complex effects of direct oral anticoagulants on dilute Russell's viper venom time assaysAndreas Hillarp, Karin Strandberg, Kerstin M Gustafsson, et al.
Thrombosis Research|May 9, 2009
Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarinMattias Wieloch, Andreas Hillarp, Karin Strandberg, et al.
Journal of Hypertension|July 3, 2015
Higher levels of von Willebrand factor in patients with syncope due to orthostatic hypotensionNazim Isma, Richard Sutton, Andreas Hillarp, et al.
Pageof 7